Tag archief: English Only

Arrowhead and Takeda Announce Topline Results from SEQUOIA Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

− Fibrosis regression observed in 50% of patients receiving fazirsiran − Median reductions of 94% of Z-AAT accumulation in the liver and mean reduction of...

Ardoq Named to Denmark’s SKI Procurement Service for the Public Sector

Inclusion Streamlines Process for Public Organizations to Adopt Ardoq’s Enterprise Architecture Tool OSLO, Norway–(BUSINESS WIRE)– Ardoq, a SaaS company reinventing Enterprise Architecture (EA) for today’s...

Alibaba Cloud Unveils Its First International Product Innovation Center and Partner Management Center

Leading cloud service provider manifests its commitment to global customers, starting from its international headquarters in Singapore The cloud leader also attains the highest tier...

Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases

Transaction focused on Bylvay® (odevixibat), the first-approved treatment in progressive familial intrahepatic cholestasis in U.S. and E.U., with potential in other rare diseases Acquisition aligned...

Alipay+ promotes QR code connectivity, paving ways for a cash-free, mobile friendly travel experience in Chinese mainland for Asian consumers

– AlipayHK users are now able to pay for their metro rides in Shenzhen using their local app, as China begins to optimize regulations on...

Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint

The LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival The full LUNAR data will be presented...

Takeda Announces Favorable Phase 3 Safety and Efficacy Results of TAK-755 as Compared to Standard of Care in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Results are From First and Only Phase 3 Trial in cTTP, an Ultra-Rare Disease with Limited Treatment Options cTTP is Caused by a Deficiency in...

Sofinnova Partners Welcomes Mano Iyer as Venture Partner

PARIS–(BUSINESS WIRE)– Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the appointment of Manohar (Mano)...

Rimini Street to Present at the 25th Annual Needham Growth Conference

LAS VEGAS–(BUSINESS WIRE)– Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and...

ENHERTU® Type II Variation Application Validated by EMA for the Treatment of HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Submission based on DESTINY-Lung02 and DESTINY-Lung01 phase 2 trial results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a clinically meaningful tumor response TOKYO &...

Tiedemann Group and Alvarium Investments Complete Business Combination with Cartesian Growth Corporation

– Alvarium Tiedemann Holdings to Commence Trading on NASDAQ Under Ticker “ALTI” on January 4, 2023 – NEW YORK–(BUSINESS WIRE)– Tiedemann Group (“Tiedemann”), Alvarium Investments...

BearingPoint boosts banking, insurance and asset management capabilities by acquiring Levo Consultants

Synergies with Levo Consultants will enable the management and technology consultancy to approach customers with stronger offerings and teams. AMSTERDAM–(BUSINESS WIRE)– BearingPoint, a European management...

Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva

The CRL is related to the U.S. FDA’s previous request for additional information on palovarotene clinical trial data Ipsen anticipates responding to the request in...

Merck Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates

Not intended for UK-, US- or Canada-based media Collaboration complements Merck’s internal expertise and in-house ADC approach Companies focused on discovering novel STING-agonist ADCs for...

Samsung Electronics Develops Industry’s First 12nm-Class DDR5 DRAM

Set to begin mass production in 2023, Samsung’s new DRAM will advance next-generation computing, data centers and AI applications with industry-leading performance and greater power...